Frenkel Ran 4
4 · Karyopharm Therapeutics Inc. · Filed May 11, 2020
Insider Transaction Report
Form 4
Frenkel Ran
EVP, WW Development Operations
Transactions
- Sale
Common Stock
2020-05-07$20.00/sh−1,974$39,480→ 35,088 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]Includes 996 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan.